ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 203 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,488,000 | -28.3% | 211,428 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $2,075,000 | -12.8% | 211,428 | -2.4% | 0.01% | -18.2% |
| Q3 2019 | $2,379,000 | -5.5% | 216,634 | +0.1% | 0.01% | -8.3% |
| Q2 2019 | $2,518,000 | +18.3% | 216,508 | -2.9% | 0.01% | +20.0% |
| Q1 2019 | $2,128,000 | -2.6% | 223,030 | -1.5% | 0.01% | -16.7% |
| Q4 2018 | $2,184,000 | -32.1% | 226,527 | +0.4% | 0.01% | -20.0% |
| Q3 2018 | $3,216,000 | +16.3% | 225,650 | -2.1% | 0.02% | +7.1% |
| Q2 2018 | $2,765,000 | -4.3% | 230,429 | -1.5% | 0.01% | 0.0% |
| Q1 2018 | $2,889,000 | -15.0% | 233,899 | +0.1% | 0.01% | -12.5% |
| Q4 2017 | $3,399,000 | -29.5% | 233,630 | -31.1% | 0.02% | -36.0% |
| Q3 2017 | $4,822,000 | +11.2% | 338,840 | -0.3% | 0.02% | +8.7% |
| Q2 2017 | $4,335,000 | +0.9% | 339,736 | +0.3% | 0.02% | -4.2% |
| Q1 2017 | $4,297,000 | +76.1% | 338,843 | +41.8% | 0.02% | +71.4% |
| Q4 2016 | $2,440,000 | -22.9% | 239,016 | -0.6% | 0.01% | -22.2% |
| Q3 2016 | $3,166,000 | +3.3% | 240,408 | -0.4% | 0.02% | 0.0% |
| Q2 2016 | $3,065,000 | -5.0% | 241,313 | -1.2% | 0.02% | -5.3% |
| Q1 2016 | $3,225,000 | -13.7% | 244,150 | +0.5% | 0.02% | -13.6% |
| Q4 2015 | $3,735,000 | +25.7% | 242,876 | +1.4% | 0.02% | +22.2% |
| Q3 2015 | $2,971,000 | +0.6% | 239,584 | +11.0% | 0.02% | +12.5% |
| Q2 2015 | $2,952,000 | +14.6% | 215,804 | +0.2% | 0.02% | +14.3% |
| Q1 2015 | $2,576,000 | -6.5% | 215,349 | -0.2% | 0.01% | -6.7% |
| Q4 2014 | $2,755,000 | -4.8% | 215,770 | 0.0% | 0.02% | -6.2% |
| Q3 2014 | $2,895,000 | -53.8% | 215,770 | -44.7% | 0.02% | -54.3% |
| Q2 2014 | $6,261,000 | +75.9% | 390,077 | +97.5% | 0.04% | +66.7% |
| Q1 2014 | $3,560,000 | +18.5% | 197,460 | +1.6% | 0.02% | +16.7% |
| Q4 2013 | $3,005,000 | +4.0% | 194,345 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $2,890,000 | +6.3% | 194,345 | -7.5% | 0.02% | 0.0% |
| Q2 2013 | $2,718,000 | -4.4% | 210,014 | +0.3% | 0.02% | -10.0% |
| Q1 2013 | $2,844,000 | – | 209,293 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |